U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You
Contact Us FAQs Site Map About MedelinePlus
español

Reuters Health Information Logo

Kidney stone treatment not linked to hypertension

Printer-friendly version Printer-friendly version

Reuters Health

Thursday, May 8, 2008

NEW YORK (Reuters Health) - The use of shock waves to break up kidney stones does not seem to lead to the development of high blood pressure, according to Japanese researchers.

By focusing shock waves on the kidneys, stones can be shattered into small particles, which are then flushed out with the normal flow of urine. However, there have been concerns that the procedure, called shock wave lithotripsy or SWL, could damage the kidneys and lead to hypertension.

Reassuringly, data from long-term follow-up "suggests that SWL is a safe treatment," Dr. Yoshikazu Sato told Reuters Health,

Sato and colleagues at Sanjukai Hospital, Sapporo, studied 772 patients with kidney stones who underwent shock wave lithotripsy, comparing them with 505 patients with stones in the ureters, the tubes leading from the kidneys; they were also treated with shock wave lithotripsy, but were unlikely to have sustained kidney damage from the procedure.

Follow-up 10 years after treatment showed that in the kidney stone group, hypertension developed in 22.8 percent of men and 23.1 percent of women. Corresponding rates in the ureter stone group were 20.0 percent and 20.5 percent, the researchers report in the medical journal Urology.

Statistically, there were no differences between the groups, for men or women. Despite these reassuring findings, Sato concluded that "efforts towards minimizing damage and identification of optimal patients for SWL are required."

SOURCE: Urology, April 2008.


Reuters Health

Copyright © 2008 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Related News:
More News on this Date

Related MedlinePlus Pages: